| scholarly article | Q13442814 |
| review article | Q7318358 |
| P356 | DOI | 10.1177/1753944709353173 |
| P698 | PubMed publication ID | 19965898 |
| P2093 | author name string | Takashi Akasaka | |
| Toshio Imanishi | |||
| Hiroto Tsujioka | |||
| P2860 | cites work | Telomere Length as an Indicator of Biological Aging | Q59275532 |
| Vascular Endothelial Cadherin (VE‐Cadherin): Cloning and Role in Endothelial Cell‐Cell Adhesion | Q24317007 | ||
| Origins of circulating endothelial cells and endothelial outgrowth from blood | Q24599869 | ||
| Oxidized LDL upregulates angiotensin II type 1 receptor expression in cultured human coronary artery endothelial cells: the potential role of transcription factor NF-kappaB | Q28141433 | ||
| Ageing and telomeres: a study into organ- and gender-specific telomere shortening | Q28210726 | ||
| The RNA component of human telomerase | Q28288330 | ||
| Isolation of putative progenitor endothelial cells for angiogenesis | Q28302884 | ||
| Impaired angiogenesis in glutathione peroxidase-1-deficient mice is associated with endothelial progenitor cell dysfunction | Q28586372 | ||
| The serial cultivation of human diploid cell strains | Q29547356 | ||
| Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/progestin Replacement Study (HERS) Research Group | Q29615228 | ||
| Telomerase catalytic subunit homologs from fission yeast and human | Q29615387 | ||
| Age-dependent depression in circulating endothelial progenitor cells in patients undergoing coronary artery bypass grafting | Q30320636 | ||
| Interaction of oestrogen receptor with the regulatory subunit of phosphatidylinositol-3-OH kinase | Q30439814 | ||
| Number and activity of endothelial progenitor cells from peripheral blood in patients with hypercholesterolaemia | Q30760797 | ||
| Constitutive human telomerase reverse transcriptase expression enhances regenerative properties of endothelial progenitor cells | Q30844927 | ||
| Relevance of monocytic features for neovascularization capacity of circulating endothelial progenitor cells | Q33194273 | ||
| Profoundly reduced neovascularization capacity of bone marrow mononuclear cells derived from patients with chronic ischemic heart disease | Q33200016 | ||
| Endothelial progenitor cells dysfunction and senescence: contribution to oxidative stress | Q33572269 | ||
| Telomere length and replicative aging in human vascular tissues | Q33763501 | ||
| Characterization of two types of endothelial progenitor cells and their different contributions to neovasculogenesis. | Q34286784 | ||
| Hormone therapy and in-hospital survival after myocardial infarction in postmenopausal women | Q34429767 | ||
| Telomere length regulation during postnatal development and ageing in Mus spretus | Q34632719 | ||
| Antioxidants, oxidative damage and oxygen deprivation stress: a review | Q35037504 | ||
| Endothelial progenitor cells: mobilization, differentiation, and homing | Q35114634 | ||
| Loss of bone marrow-derived vascular progenitor cells leads to inflammation and atherosclerosis | Q35562127 | ||
| Aging-associated changes in indices of thrombin generation and protein C activation in humans. Normative Aging Study | Q35582687 | ||
| Telomeres and cardiovascular disease: does size matter? | Q35697295 | ||
| Expression of telomerase activity in human endometrium is localized to epithelial glandular cells and regulated in a menstrual phase-dependent manner correlated with cell proliferation | Q35786049 | ||
| Reactive oxygen species, vascular oxidative stress, and redox signaling in hypertension: what is the clinical significance? | Q35840821 | ||
| Gender differences in circulating endothelial progenitor cell colony-forming capacity and migratory activity in middle-aged adults | Q35847119 | ||
| Endothelial progenitor cells: characterization and role in vascular biology | Q35867837 | ||
| Telomerase activity, cell proliferation, and cancer | Q36166271 | ||
| The estrogen effects on endothelial repair and mitogen-activated protein kinase activation are abolished in endothelial nitric-oxide (NO) synthase knockout mice, but not by NO synthase inhibition by N-nitro-L-arginine methyl ester | Q36482278 | ||
| Stem cells and the regeneration of the aging cardiovascular system | Q36803362 | ||
| Endothelial progenitor cell therapy for the treatment of coronary disease, acute MI, and pulmonary arterial hypertension: current perspectives | Q37017549 | ||
| Vascular actions of estrogens: functional implications | Q37088243 | ||
| Pharmacological approaches to improve endothelial repair mechanisms | Q37269376 | ||
| Nitric oxide production contributes to the angiogenic properties of vascular endothelial growth factor in human endothelial cells | Q37376612 | ||
| Evidence for the importance of angiotensin II type 1 receptor in ischemia-induced angiogenesis | Q39737596 | ||
| Role of host angiotensin II type 1 receptor in tumor angiogenesis and growth | Q39778121 | ||
| Differential expression of EDF-1 and endothelial nitric oxide synthase by proliferating, quiescent and senescent microvascular endothelial cells. | Q40391146 | ||
| Transforming growth factor-beta inhibition of proteasomal activity: a potential mechanism of growth arrest. | Q40662685 | ||
| Estrogen reduces angiotensin II-induced nitric oxide synthase and NAD(P)H oxidase expression in endothelial cells | Q40678313 | ||
| Estrogens and atherosclerosis | Q41455799 | ||
| Effect of angiotensin II on hematopoietic progenitor cell proliferation | Q41752238 | ||
| Essential role of bone marrow fibroblast growth factor-2 in the effect of estradiol on reendothelialization and endothelial progenitor cell mobilization. | Q41883424 | ||
| Antioxidative stress-associated genes in circulating progenitor cells: evidence for enhanced resistance against oxidative stress | Q42462175 | ||
| Estradiol enhances recovery after myocardial infarction by augmenting incorporation of bone marrow-derived endothelial progenitor cells into sites of ischemia-induced neovascularization via endothelial nitric oxide synthase-mediated activation of ma | Q42492012 | ||
| eNOS activity is reduced in senescent human endothelial cells: Preservation by hTERT immortalization | Q42511987 | ||
| Noncardiovascular disease outcomes during 6.8 years of hormone therapy: Heart and Estrogen/progestin Replacement Study follow-up (HERS II). | Q42679385 | ||
| Increase in circulating endothelial progenitor cells by statin therapy in patients with stable coronary artery disease | Q43645304 | ||
| Number and migratory activity of circulating endothelial progenitor cells inversely correlate with risk factors for coronary artery disease | Q43664648 | ||
| Peroxynitrite increases iNOS through NF-kappaB and decreases prostacyclin synthase in endothelial cells | Q43852568 | ||
| Hypertension, angiotensin II, and oxidative stress | Q44035389 | ||
| 17Beta-estradiol up-regulates vascular endothelial growth factor receptor-2 expression in human myometrial microvascular endothelial cells: role of estrogen receptor-alpha and -beta | Q44127024 | ||
| Long-term (three years) effect of estrogen replacement therapy on major adverse cardiac events in postmenopausal women after intracoronary stenting | Q44194671 | ||
| Estrogen causes dynamic alterations in endothelial estrogen receptor expression | Q44201587 | ||
| Estrogen increases bone marrow-derived endothelial progenitor cell production and diminishes neointima formation | Q44480707 | ||
| Aging, progenitor cell exhaustion, and atherosclerosis | Q44513172 | ||
| Association between estrogen receptor alpha gene variation and cardiovascular disease | Q44643928 | ||
| Estrogen-mediated, endothelial nitric oxide synthase-dependent mobilization of bone marrow-derived endothelial progenitor cells contributes to reendothelialization after arterial injury | Q44693870 | ||
| Improvement in endothelial progenitor cells from peripheral blood by ramipril therapy in patients with stable coronary artery disease | Q44960467 | ||
| Angiotensin II accelerates endothelial progenitor cell senescence through induction of oxidative stress | Q45219131 | ||
| Hepatocyte growth factor, but not vascular endothelial growth factor, attenuates angiotensin II-induced endothelial progenitor cell senescence | Q45881660 | ||
| Influence of menstrual cycle on circulating endothelial progenitor cells. | Q46195154 | ||
| Stimulation of endothelial progenitor cells: a new putative therapeutic effect of angiotensin II receptor antagonists | Q46378624 | ||
| Estrogen-stimulated endothelial repair requires osteopontin | Q46388529 | ||
| Antioxidative effects of exercise training in patients with chronic heart failure: increase in radical scavenger enzyme activity in skeletal muscle | Q46421406 | ||
| Impaired progenitor cell activity in age-related endothelial dysfunction | Q46464362 | ||
| Estrogen reduces endothelial progenitor cell senescence through augmentation of telomerase activity | Q46644748 | ||
| Estrogen reduces angiotensin II-induced acceleration of senescence in endothelial progenitor cells | Q46647567 | ||
| Endothelial progenitor cell senescence is accelerated in both experimental hypertensive rats and patients with essential hypertension | Q46691696 | ||
| Gender differences in endothelial progenitor cells and cardiovascular risk profile: the role of female estrogens | Q46752443 | ||
| Parameters of antioxidative defense in type 2 diabetic patients with cardiovascular complications | Q46843462 | ||
| Oxidized low density lipoprotein impairs endothelial progenitor cells by regulation of endothelial nitric oxide synthase | Q46979835 | ||
| Estrogen-mediated endothelial progenitor cell biology and kinetics for physiological postnatal vasculogenesis. | Q51744725 | ||
| Telomerase maintains telomere structure in normal human cells. | Q52551445 | ||
| Peripheral blood CD34+KDR+ endothelial progenitor cells are determinants of subclinical atherosclerosis in a middle-aged general population. | Q52572477 | ||
| Age-related BM-MNC dysfunction hampers neovascularization. | Q53535468 | ||
| Estrogen receptors alpha and beta mediate contribution of bone marrow-derived endothelial progenitor cells to functional recovery after myocardial infarction. | Q53589570 | ||
| Human endothelial progenitor cells tolerate oxidative stress due to intrinsically high expression of manganese superoxide dismutase. | Q53888121 | ||
| Telomere length and possible link to X chromosome | Q57085573 | ||
| Reduced Number of Circulating Endothelial Progenitor Cells in Hypogonadal Men | Q57572339 | ||
| P433 | issue | 1 | |
| P921 | main subject | endothelium | Q111140 |
| P304 | page(s) | 55-69 | |
| P577 | publication date | 2009-12-04 | |
| P1433 | published in | Therapeutic advances in cardiovascular disease | Q26842002 |
| P1476 | title | Endothelial progenitor cell senescence--is there a role for estrogen? | |
| P478 | volume | 4 |
| Q37623629 | Age-dependent Effects of 17β-estradiol on the dynamics of estrogen receptor β (ERβ) protein-protein interactions in the ventral hippocampus |
| Q42728764 | Cleaved high-molecular-weight kininogen accelerates the onset of endothelial progenitor cell senescence by induction of reactive oxygen species |
| Q43420530 | Effects of dihydrotestosterone on adhesion and proliferation via PI3-K/Akt signaling in endothelial progenitor cells |
| Q58362653 | Gene therapy in peripheral artery disease |
| Q37860257 | Hormones, heart disease, and health: individualized medicine versus throwing the baby out with the bathwater |
| Q43872474 | Hormones, heart disease, and health: individualized medicine versus throwing the baby out with the bathwater |
| Q36353200 | Immortalized functional endothelial progenitor cell lines from umbilical cord blood for vascular tissue engineering. |
| Q93015658 | Quantifying Age-Related Changes in Skin Wound Metabolism Using In Vivo Multiphoton Microscopy |
| Q47164880 | Sex Differences in Circulating Progenitor Cells |
| Q35618768 | Therapeutic Angiogenesis by Gene Therapy for Critical Limb Ischemia: Choice of Biological Agent |
Search more.